FINWIRES · TerminalLIVE
FINWIRES

Ross Stores Raises Full-Year Outlook Following Fiscal First-Quarter Beat

By
Ross Stores Raises Full-Year Outlook Following Fiscal First-Quarter Beat

Ross Stores (ROST) shares rose early Friday after the discount retailer lifted its full-year outlook and reported better-than-expected fiscal first-quarter results.

The company now anticipates earnings to come in between $7.50 and $7.74 per share for fiscal 2026, Chief Executive Jim Conroy said in a statement late Thursday. The retailer previously projected the metric to be in a range of $7.02 to $7.36, while the current consensus on FactSet is for $7.68.

Same-store sales are pegged to grow by 6% to 7% for the ongoing fiscal year, according to Conroy, compared with prior projections for a gain of 3% to 4%. The Street is looking for an increase of 6.7%.

"As our efforts to improve topline growth continue, we remain focused on disciplined, consistent execution across the business," Conroy said. "Moving forward, we believe we are well positioned to capture additional market share and drive profitable growth over the long term."

The stock rose 5.3% in the most recent premarket activity.

Earlier in the week, off-price retailer TJX (TJX) raised its full-year outlook after posting stronger-than-expected fiscal first-quarter results. Target (TGT) also lifted its fiscal 2026 sales growth guidance, while retail giant Walmart (WMT) issued a downbeat fiscal second-quarter earnings outlook.

Ross Stores' EPS climbed to $2.02 for the three-month period ended May 2 from $1.47 the year before, topping the average analyst estimate of $1.73. Sales advanced 21% to $6.01 billion, ahead of the Street's view for $5.64 billion.

"Momentum was solid throughout the quarter, with broad-based strength across the business," according to Conroy. The CEO cited customer traffic as the "primary driver" of the robust sales trend, while high consumer spending related to tax refunds also benefited the retailer's results.

Comparable store sales jumped 17%, exceeding the market's forecast for growth of 9.4%, buoyed by an increase in the number of transactions, Chief Financial Officer William Sheehan said during an earnings call, according to a FactSet transcript.

"The quarter started strongly as we transitioned well from the holiday selling season into spring, supported by more balanced inventory levels that allowed us to drive strong demand in February where we have historically struggled," Conroy said on the call. "The strength continued with solid mid-teen comps for the balance of the quarter."

For the current quarter, Ross Stores expects EPS to be at $1.85 to $1.93 and sales to increase by 9% to 11% on an annual basis, Sheehan told analysts. The Street is looking for EPS of $1.92 and sales of $6.09 billion. Comparable store sales are anticipated to increase by 6% to 7%, compared with the current average analyst estimate on FactSet for growth of 7%.

Related Articles

Australia's Competition Watchdog Fines Coles, Brownes Over Milk Supply Agreements
US Markets

Australia's Competition Watchdog Fines Coles, Brownes Over Milk Supply Agreements

Coles (ASX:COL) and Brownes Foods Operations each paid AU$39,600 in penalties after Australia's competition watchdog issued two infringement notices for separate alleged breaches of the country's mandatory dairy industry code.The Australian Competition and Consumer Commission (ACCC) alleged Coles Supermarkets Australia published two milk supply agreements requiring farmers to supply milk exclusively to Coles while imposing caps on the maximum volume of milk that could be produced, according to a Friday press release.Separately, the ACCC said Brownes published two milk supply agreements that did not clearly specify minimum prices across the full supply period or explain the basis for those prices."Dairy farmers need clear accurate information about supply terms and prices when deciding who they will supply," ACCC Deputy Chair Mick Keogh said."Volume caps in exclusive milk supply agreements are particularly concerning. They can cause significant harm to farmers by limiting milk production while also restricting their ability to supply multiple processors," Keogh added.The action comes a week after Australia's Federal Court found that Coles made false or misleading representations through its "Down Down" discount program in a separate case brought by the Australian Competition and Consumer Commission.The regulator alleged Coles offered illusory discounts on 245 products by temporarily raising prices before promoting the items as discounted.According to an earlier statement, Coles increased prices on selected products before offering them at promotional prices that were equal to or higher than their previous levels, making it harder for consumers to identify genuine discounts.The ACCC said three other dairy processors were also contacted over minor alleged breaches of the code and had taken steps to improve compliance after receiving warnings.Coles purchases about 490 million liters of fresh milk annually across southern Australia and Western Australia, while Brownes purchases about 150 million liters annually from about 50 dairy farmers in Western Australia, according to the ACCC.

$ASX:COL
Puig Shares Plunge as Merger Talks with Estée Lauder Called Off
US Markets

Puig Shares Plunge as Merger Talks with Estée Lauder Called Off

Puig Brands (PUIG.MC) shares tumbled more than 13% by Friday midday after negotiations for a proposed combination with Estée Lauder fell through.The Spanish fashion and beauty company and New York-listed Estée Lauder announced on Thursday that they failed to reach an agreement to combine their respective businesses.The potential merger, first disclosed March 23, would have created a $40 billion luxury beauty group, Reuters noted. The transaction would have combined Estée Lauder brands like Tom Ford, Clinique and MAC with Puig's own labels, including Carolina Herrera and Charlotte Tilbury.Puig Chief Executive Officer Jose Manuel Albesa said the decision will not affect the company's strategic growth plans or its long-term value creation."Our robust capital structure gives us flexibility to pursue a range of strategic choices aligned with our long-term priorities. We will continue to take a highly selective, value-driven approach to M&A to further complement our portfolio," Albesa added.Meanwhile, Estée Lauder intends to focus on the execution of its Beauty Reimagined ​strategy and prioritize its long-term growth. President and Chief Executive Officer Stéphane de La Faverie said the company will "continue to evaluate and evolve our portfolio to ensure we have the right assets to drive the most compelling growth opportunities, including both potential acquisitions and divestitures."

$PUIG.MC
CVC Lands Groupe Bruxelles Lambert's Support to Make EUR11 Billion Bid for Italy's Recordati
US Markets

CVC Lands Groupe Bruxelles Lambert's Support to Make EUR11 Billion Bid for Italy's Recordati

CVC Capital Partners (CVC.AS) secured backing from Groupe Bruxelles Lambert (GBLB.BR) to move ahead with a 10.7 billion-euro bid for Italian pharmaceutical company Recordati (REC.MI).A consortium led by the two investment firms on Friday launched a voluntary cash tender offer for all of Recordati's shares at 51.29 euros per share. The per-share price reflects a 12.89% premium to Recordati's closing price on March 25, just before CVC first made a non-binding approach.CVC-controlled Rossini, which owns a 46.82% stake in Recordati, agreed to tender its shares under the offer. The buyers will also have support from Abu Dhabi Investment Authority's Luxinva, CPP Investment Board Private Holdings, PSP Europe, StepStone-advised funds, AlpInvest-advised funds, MGG Strategic, CapSol funds, and Andrea Recordati.The deal is expected to close in the fourth quarter, subject to regulatory approvals and acceptance by shareholders representing at least 66.67% of Recordati's share capital. Following the tender offer, Recordati is intended to be delisted from Euronext Milan and under joint control of the consortium.CVC in 2018 acquired a majority stake in the pharmaceutical company, which was founded in the early 1900s as a small pharmacy. It now has divisions covering specialty and primary care, rare diseases, along with industrial operations.CVC and Groupe Bruxelles Lambert shares inched up in early morning trading in Amsterdam and Brussels, respectively, while Recordati's stock was down slightly in Milan.

$CVC.AS$GBLB.BR$REC.MI